The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-acetamido-5-(2-(3,4-dihydroxybenzylidene)hydrazine-1-carbonyl)-N-(4-methoxyphenyl)-2-(phenylamino)thiophene-3-carboxamide ID: ALA5268406
Chembl Id: CHEMBL5268406
Max Phase: Preclinical
Molecular Formula: C28H25N5O6S
Molecular Weight: 559.60
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(NC(=O)c2c(Nc3ccccc3)sc(C(=O)N/N=C/c3ccc(O)c(O)c3)c2NC(C)=O)cc1
Standard InChI: InChI=1S/C28H25N5O6S/c1-16(34)30-24-23(26(37)31-19-9-11-20(39-2)12-10-19)28(32-18-6-4-3-5-7-18)40-25(24)27(38)33-29-15-17-8-13-21(35)22(36)14-17/h3-15,32,35-36H,1-2H3,(H,30,34)(H,31,37)(H,33,38)/b29-15+
Standard InChI Key: MOTFKPFRGPPMMG-WKULSOCRSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 559.60Molecular Weight (Monoisotopic): 559.1526AlogP: 4.89#Rotatable Bonds: 9Polar Surface Area: 161.38Molecular Species: NEUTRALHBA: 9HBD: 6#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 8.92CX Basic pKa: 1.13CX LogP: 6.00CX LogD: 5.98Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.10Np Likeness Score: -1.11
References 1. Soltan OM, Shoman ME, Abdel-Aziz SA, Narumi A, Konno H, Abdel-Aziz M.. (2021) Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy., 225 [PMID:34450497 ] [10.1016/j.ejmech.2021.113768 ]